Clinical Outcomes of Complete Revascularization in Acute Myocardial Infarction Patients With High Bleeding Risk and Multivessel Disease
- 7 July 2026
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e042507
Abstract
Background: High bleeding risk (HBR) is associated with an increased risk of both ischemic and bleeding events and is known to have a worse prognosis than non‐HBR in patients with acute myocardial infarction. However, data regarding the prognostic impact of complete revascularization (CR) in acute myocardial infarction and multivessel disease patients complicated by HBR remain limited. Methods: A total of 13 460 patients with acute myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention for infarct‐related artery were selected from the nationwide Korean registry from 2011 to 2020. Primary outcome was major adverse cardiac and cerebrovascular events during 3 years of follow‐up. Results: Of the 13 460 patients, 4401 (32.7%) were classified as the group with HBR according to modified Academic Research Consortium‐HBR criteria and 1577 patients (35.8%) underwent CR. Among the group without HBR, 3911 patients (43.2%) underwent CR for noninfarct‐related artery. The group with HBR had significantly higher risk of major adverse cardiac and cerebrovascular events (non‐HBR versus HBR; 16.4% versus 35.7%; adjusted hazard ratio [HR], 1.70 [95% CI, 1.56–1.85]; P P P P P =0.572) and without HBR (4.2% versus 5.0%, adjusted HR, 0.98 [95% CI, 0.78–1.23], P =0.867). Conclusions: In patients with acute myocardial infarction and multivessel disease, CR was associated with a lower risk of major adverse cardiac and cerebrovascular events compared with incomplete revascularization in both HBR and non‐HBR. Registration: KAMIR‐NIH; KCT‐0000863, KAMIR‐V; KCT‐0008355.Keywords
This publication has 31 references indexed in Scilit:
- Outcomes after percutaneous coronary intervention or bypass surgery for ischemic cardiomyopathyRevista Española de Cardiología (English Edition), 2024
- Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding RiskJAMA Cardiology, 2024
- Intravascular imaging-guided percutaneous coronary intervention in patients with acute myocardial infarction and cardiogenic shockRevista Española de Cardiología (English Edition), 2024
- Complete versus culprit‐only strategy in older MI patients with multivessel diseaseCatheterization and Cardiovascular Interventions, 2022
- Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic ShockJACC, 2018
- ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart DiseaseJournal of Nuclear Cardiology, 2017
- Radial Access Reduces Mortality in Patients With Acute Coronary SyndromesJACC: Cardiovascular Interventions, 2016
- Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThe Lancet, 2015
- Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral AnticoagulationJACC, 2013
- A New Era of Prospective Real-World Safety EvaluationJACC: Cardiovascular Interventions, 2011